We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+0.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4B
AUM Growth
+$261M
(+7%)
Cap. Flow
+$281M
Cap. Flow
% of AUM
7.02%
Top 10 Holdings %
Top 10 Hldgs %
19.74%
Holding
679
New
127
Increased
246
Reduced
223
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$104M |
| 2 |
Apple
AAPL
|
+$60.7M |
| 3 |
Amazon
AMZN
|
+$47.5M |
| 4 |
American Express
AXP
|
+$28.7M |
| 5 |
Travelers Companies
TRV
|
+$27.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Solar
FSLR
|
+$28.1M |
| 2 |
Johnson & Johnson
JNJ
|
+$28.1M |
| 3 |
Clorox
CLX
|
+$26.2M |
| 4 |
TJX Companies
TJX
|
+$24.8M |
| 5 |
McKesson
MCK
|
+$23.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.39% |
| 2 | Financials | 11.87% |
| 3 | Technology | 10.68% |
| 4 | Communication Services | 10.67% |
| 5 | Consumer Discretionary | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEE
301
DELISTED
Sealed Air
SEE
| $2.19M | 0.05% |
45,797
+19,060
| +71% | +$834K |
|
302
Halozyme
HALO
$9.72B
| $2.19M | 0.05% |
232,000
+11,400
| +5% | +$107K |
|
|
FITB
303
Fifth Third Bancorp
FITB
$52B
| $2.16M | 0.05% |
129,918
-263,276
| -67% | -$4.33M |
|
304
Darden Restaurants
DRI
$22.5B
| $2.14M | 0.05% |
+32,506
| New | +$2.06M |
|
305
Walmart Inc
WMT
$871B
| $2.14M | 0.05% |
94,371
+498
| +0.5% | +$10.9K |
|
|
IPG
306
DELISTED
Interpublic Group of Companies
IPG
| $2.13M | 0.05% |
+93,448
| New | +$2.02M |
|
307
Hewlett Packard
HPE
$63.2B
| $2.07M | 0.05% |
202,036
-380,130
| -65% | -$3.18M |
|
|
FCS
308
DELISTED
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
| $2.06M | 0.05% |
+103,521
| New | +$2.1M |
|
309
MetLife
MET
$61B
| $2.01M | 0.05% |
51,676
-5,984
| -10% | -$224K |
|
|
CEMP
310
DELISTED
Cempra, Inc.
CEMP
| $2M | 0.05% |
115,000
-15,000
| -12% | -$272K |
|
|
RDUS
311
DELISTED
Radius Health, Inc.
RDUS
| $2M | 0.05% |
64,000
-26,000
| -29% | -$899K |
|
312
United Therapeutics
UTHR
$26.3B
| $2M | 0.05% |
18,000
-15,100
| -46% | -$1.91M |
|
313
Canadian Natural Resources
CNQ
$96.9B
| $1.96M | 0.05% |
149,881
-29,650
| -17% | -$316K |
|
314
Kroger
KR
$34.8B
| $1.95M | 0.05% |
51,315
+2,773
| +6% | +$107K |
|
315
Kraft Heinz
KHC
$30.4B
| $1.94M | 0.05% |
24,878
+2,997
| +14% | +$224K |
|
|
ARRY
316
DELISTED
Array Biopharma Inc
ARRY
| $1.93M | 0.05% |
+659,000
| New | +$1.97M |
|
317
Netflix
NFLX
$292B
| $1.93M | 0.05% |
190,010
+13,290
| +8% | +$130K |
|
|
EPZM
318
DELISTED
Epizyme, Inc
EPZM
| $1.93M | 0.05% |
160,000
-21,000
| -12% | -$212K |
|
|
AGEN
319
Agenus
AGEN
$249M
| $1.89M | 0.05% |
23,320
| – | – |
|
320
Edwards Lifesciences
EW
$47.6B
| $1.89M | 0.05% |
+64,686
| New | +$1.78M |
|
321
TC Energy
TRP
$73.5B
| $1.89M | 0.05% |
48,040
-7,883
| -14% | -$276K |
|
322
Northern Trust
NTRS
$22.2B
| $1.88M | 0.05% |
29,055
+12,131
| +72% | +$760K |
|
323
Sysco
SYY
$39.7B
| $1.88M | 0.05% |
40,353
+14,051
| +53% | +$606K |
|
324
Brookfield
BN
$102B
| $1.85M | 0.05% |
151,337
-194,991
| -56% | -$2.1M |
|
325
Lexicon Pharmaceuticals
LXRX
$1.02B
| $1.82M | 0.05% |
153,000
-12,000
| -7% | -$126K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q1 2016 Portfolio in Review
As of Q1 2016, Candriam SCA held 679 positions worth $4B, up 7% from $3.74B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Candriam SCA deployed $281M of net new capital in Q1 2016, opening 127 new positions and adding to 246 existing holdings. Its largest new stake was Amgen: 700,333 shares worth $104M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 29% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was First Solar, an estimated $28.1M trimmed.
- Candriam SCA's largest Q1 2016 buy was Amgen: 700,333 shares worth $104M.
- Candriam SCA added most to Mead Johnson Nutrition Company in Q1 2016, an estimated $22.2M increase.
- Candriam SCA's biggest Q1 2016 reduction was First Solar, cutting an estimated $28.1M.
- Candriam SCA fully exited Avangrid, Inc. in Q1 2016, selling an estimated $9.6M.
- Candriam SCA's ten largest holdings make up 20% of its $4B portfolio in Q1 2016.
- Candriam SCA opened 127 new positions and closed 43 in Q1 2016.
- Candriam SCA's portfolio value rose 7% quarter-over-quarter to $4B.
Based on Candriam SCA's 13F filing for Q1 2016, filed 27 Apr 2016.